70
Views
151
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Aberrant Eukaryotic Translation Initiation Factor 4E-Dependent mRNA Transport Impedes Hematopoietic Differentiation and Contributes to Leukemogenesis

, , , , , , & show all
Pages 8992-9002 | Received 28 May 2003, Accepted 15 Sep 2003, Published online: 27 Mar 2023

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (12)

Katherine L.B. Borden & Laurent Volpon. (2020) The diversity, plasticity, and adaptability of cap-dependent translation initiation and the associated machinery. RNA Biology 17:9, pages 1239-1251.
Read now
Rory M. Shallis, Jan Philipp Bewersdorf, Prajwal C. Boddu & Amer M. Zeidan. (2019) Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia. Expert Review of Anticancer Therapy 19:8, pages 717-729.
Read now
Kankan Chen, Yue Chen, Zhi Chen, Yuye Shi, Zhengmei He, Banghe Ding, Chunling Wang & Liang Yu. (2018) miR-134 increases the antitumor effects of cytarabine by targeting Mnks in acute myeloid leukemia cells. OncoTargets and Therapy 11, pages 3141-3147.
Read now
Filippa Pettersson, Sonia V del Rincon & Wilson H Miller$suffix/text()$suffix/text(). (2014) Eukaryotic translation initiation factor 4E as a novel therapeutic target in hematological malignancies and beyond. Expert Opinion on Therapeutic Targets 18:9, pages 1035-1048.
Read now
Laurent Volpon, Michael J. Osborne, Biljana Culjkovic-Kraljacic & Katherine L.B. Borden. (2013) eIF4E3, a new actor in mRNA metabolism and tumor suppression. Cell Cycle 12:8, pages 1159-1160.
Read now
Peter Noy, Hannah Williams, Anyaporn Sawasdichai, Kevin Gaston & Padma-Sheela Jayaraman. (2010) PRH/Hhex Controls Cell Survival through Coordinate Transcriptional Regulation of Vascular Endothelial Growth Factor Signaling. Molecular and Cellular Biology 30:9, pages 2120-2134.
Read now
Ivan Topisirovic, Nadeem Siddiqui, Slobodanka Orolicki, Lucy A. Skrabanek, Mathieu Tremblay, Trang Hoang & Katherine L. B. Borden. (2009) Stability of Eukaryotic Translation Initiation Factor 4E mRNA Is Regulated by HuR, and This Activity Is Dysregulated in Cancer. Molecular and Cellular Biology 29:5, pages 1152-1162.
Read now
Piotr Smolewski. (2006) Investigating mammalian target of rapamycin inhibitors for their anticancer properties. Expert Opinion on Investigational Drugs 15:10, pages 1201-1227.
Read now
Montserrat Blázquez-Domingo, Godfrey Grech & Marieke von Lindern. (2005) Translation Initiation Factor 4E Inhibits Differentiation of Erythroid Progenitors. Molecular and Cellular Biology 25:19, pages 8496-8506.
Read now
Ivan Topisirovic, Alex Kentsis, Jacqueline M. Perez, Monica L. Guzman, Craig T. Jordan & Katherine L. B. Borden. (2005) Eukaryotic Translation Initiation Factor 4E Activity Is Modulated by HOXA9 at Multiple Levels. Molecular and Cellular Biology 25:3, pages 1100-1112.
Read now

Articles from other publishers (139)

Ann Fernandez, Paige J. Monsen, Leonidas C. Platanias & Gary E. Schiltz. (2023) Medicinal chemistry approaches to target the MNK–eIF4E axis in cancer. RSC Medicinal Chemistry 14:6, pages 1060-1087.
Crossref
Roman Istomine, Tho-Alfakar Al-Aubodah, Fernando Alvarez, Jacob A. Smith, Carston Wagner & Ciriaco A. Piccirillo. (2023) The eIF4EBP-eIF4E axis regulates CD4+ T cell differentiation through modulation of T cell activation and metabolism. iScience 26:5, pages 106683.
Crossref
Mehdi Ghram, Gavin Morris, Biljana Culjkovic‐Kraljacic, Jean‐Clement Mars, Patrick Gendron, Lucy Skrabanek, Maria Victoria Revuelta, Leandro Cerchietti, Monica L Guzman & Katherine L B Borden. (2023) The eukaryotic translation initiation factor eIF4E reprograms alternative splicing . The EMBO Journal 42:7.
Crossref
Mashima Naksawat, Chosita Norkaew, Kantorn Charoensedtasin, Sittiruk Roytrakul & Dalina Tanyong. (2023) Anti-leukemic effect of menthol, a peppermint compound, on induction of apoptosis and autophagy. PeerJ 11, pages e15049.
Crossref
Chitra Subramanian, Katie K. Spielbauer, Robin Pearce, Kevin J. Kovatch, Mark E. Prince, Barbara N. Timmermann & Mark S. Cohen. (2022) Combination Treatment of Withalongolide a Triacetate with Cisplatin Induces Apoptosis by Targeting Translational Initiation, Migration, and Epithelial to Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma. Nutrients 14:24, pages 5398.
Crossref
Angela Rubio, Gavin D. Garland, Aristeidis Sfakianos, Robert F. Harvey & Anne E. Willis. (2022) Aberrant protein synthesis and cancer development: The role of canonical eukaryotic initiation, elongation and termination factors in tumorigenesis. Seminars in Cancer Biology 86, pages 151-165.
Crossref
Katherine L.B. Borden. (2022) Cancer cells hijack RNA processing to rewrite the message. Biochemical Society Transactions 50:5, pages 1447-1456.
Crossref
Katherine L.B. Borden. (2022) The search for genetic dark matter and lessons learned from the journey. Biochemistry and Cell Biology 100:4, pages 276-281.
Crossref
Michael J. Osborne, Laurent Volpon, Mina Memarpoor-Yazdi, Shubhadra Pillay, Aksharh Thambipillai, Sylwia Czarnota, Biljana Culjkovic-Kraljacic, Christian Trahan, Marlene Oeffinger, Victoria H. Cowling & Katherine L.B. Borden. (2022) Identification and Characterization of the Interaction Between the Methyl-7-Guanosine Cap Maturation Enzyme RNMT and the Cap-Binding Protein eIF4E. Journal of Molecular Biology 434:5, pages 167451.
Crossref
Weijun Xu, Srinivasaraghavan Kannan, Chandra S. Verma & Kassoum Nacro. (2021) Update on the Development of MNK Inhibitors as Therapeutic Agents. Journal of Medicinal Chemistry 65:2, pages 983-1007.
Crossref
Shalini Guha, Priyanka Barman, Aruniti Manawa & Sukesh R. Bhaumik. 2022. Messenger RNA Therapeutics. Messenger RNA Therapeutics 371 395 .
Biljana Culjkovic-Kraljacic & Katherine L. B. Borden. 2022. The Nuclear Pore Complex. The Nuclear Pore Complex 91 104 .
Jean-Clement Mars, Mehdi Ghram, Biljana Culjkovic-Kraljacic & Katherine L. B. Borden. (2021) The Cap-Binding Complex CBC and the Eukaryotic Translation Factor eIF4E: Co-Conspirators in Cap-Dependent RNA Maturation and Translation. Cancers 13:24, pages 6185.
Crossref
Siyu Liu, Bing Wu, Xiaomin Li, Lulu Zhao, Wen Wu & Songtao Ai. (2021) Construction and Validation of a Potent Epigenetic Modification-Related Prognostic Signature for Osteosarcoma Patients. Journal of Oncology 2021, pages 1-14.
Crossref
Magali Belpaire, Bruno Ewbank, Arnaud Taminiau, Laure Bridoux, Noémie Deneyer, Damien Marchese, Gipsi Lima-Mendez, Jean-François Baurain, Dirk Geerts & René Rezsohazy. (2021) HOXA1 Is an Antagonist of ERα in Breast Cancer. Frontiers in Oncology 11.
Crossref
Maria N. Evseeva, Daniyar T. Dyikanov, Maxim N. Karagyaur, Tatyana A. Prikazchikova, Anna F. Sheptulina, Maria S. Balashova, Timofei S. Zatsepin, Yury P. Rubtsov & Konstantin Y. Kulebyakin. (2021) Hematopoietically-expressed homeobox protein HHEX regulates adipogenesis in preadipocytes. Biochimie 185, pages 68-77.
Crossref
Benjamin Weiss, George Edward Allen, Joachim Kloehn, Karim Abid, Pascale Jaquier-Gubler & Joseph Alphonsus Curran. (2021) eIF4E3 forms an active eIF4F complex during stresses (eIF4FS) targeting mTOR and re-programs the translatome. Nucleic Acids Research 49:9, pages 5159-5176.
Crossref
Milagros Suarez, Gavin T. Blyth, Alain A. Mina, Ewa M. Kosciuczuk, Blazej Dolniak, Shira Dinner, Jessica K. Altman, Elizabeth A. Eklund, Diana Saleiro, Elspeth M. Beauchamp & Leonidas C. Platanias. (2021) Inhibitory effects of Tomivosertib in acute myeloid leukemia. Oncotarget 12:10, pages 955-966.
Crossref
Irina A. Elcheva & Vladimir S. Spiegelman. (2020) Targeting RNA-binding proteins in acute and chronic leukemia. Leukemia 35:2, pages 360-376.
Crossref
Katherine L. B. Borden. (2020) The Nuclear Pore Complex and mRNA Export in Cancer. Cancers 13:1, pages 42.
Crossref
Kexin Zhang, Qi Zhao, Zugui Li, Fangmei Fu, Hao Zhang, Junjie Fu, Minying Zheng & Shiwu Zhang. (2020) Clinicopathological Significances of Cancer Stem Cell-Associated HHEX Expression in Breast Cancer. Frontiers in Cell and Developmental Biology 8.
Crossref
Biljana Culjkovic-KraljacicLucy Skrabanek, Maria V. Revuelta, Jadwiga Gasiorek, Victoria H. Cowling, Leandro Cerchietti & Katherine L. B. Borden. (2020) The eukaryotic translation initiation factor eIF4E elevates steady-state m 7 G capping of coding and noncoding transcripts . Proceedings of the National Academy of Sciences 117:43, pages 26773-26783.
Crossref
Debora Valli, Alicja M. Gruszka & Myriam Alcalay. (2020) Has Drug Repurposing Fulfilled Its Promise in Acute Myeloid Leukaemia?. Journal of Clinical Medicine 9:6, pages 1892.
Crossref
Camila Prieto & Michael G. Kharas. (2020) RNA Regulators in Leukemia and Lymphoma. Cold Spring Harbor Perspectives in Medicine 10:5, pages a034967.
Crossref
Anna V. Wojcicki, Meena Kadapakkam, Adam Frymoyer, Norman Lacayo, Hee-Don Chae & Kathleen M. Sakamoto. (2020) Repurposing Drugs for Acute Myeloid Leukemia: A Worthy Cause or a Futile Pursuit?. Cancers 12:2, pages 441.
Crossref
Ewa M. Kosciuczuk, Aroop K. Kar, Gavin T. Blyth, Mariafausta Fischietti, Sameem Abedin, Alain A. Mina, Rebekah Siliezar, Tomasz Rzymski, Krzysztof Brzozka, Elizabeth A. Eklund, Elspeth M. Beauchamp, Frank Eckerdt, Diana Saleiro & Leonidas C. Platanias. (2019) Inhibitory effects of SEL201 in acute myeloid leukemia. Oncotarget 10:67, pages 7112-7121.
Crossref
Immacolata Maida, Paola Zanna, Stefania Guida, Anna Ferretta, Tiziana Cocco, Luigi Leonardo Palese, Paola Londei, Dario Benelli, Amalia Azzariti, Stefania Tommasi, Michele Guida, Giovanni Pellacani & Gabriella Guida. (2019) Translational control mechanisms in cutaneous malignant melanoma: the role of eIF2α. Journal of Translational Medicine 17:1.
Crossref
Jianbiao Zhou, Jessie Yiying Quah, Yvonne Ng, Jing-Yuan Chooi, Sabrina Hui-Min Toh, Baohong Lin, Tuan Zea Tan, Hiroki Hosoi, Motomi Osato, Qihui Seet, A.G. Lisa Ooi, Bertil Lindmark, Mark McHale & Wee-Joo Chng. (2019) ASLAN003, a potent dihydroorotate dehydrogenase inhibitor for differentiation of acute myeloid leukemia. Haematologica 105:9, pages 2286-2297.
Crossref
Ahmed M. Abdelaziz, Sarah Diab, Saiful Islam, Sunita K.C. Basnet, Benjamin Noll, Peng Li, Laychiluh B. Mekonnen, Jingfeng Lu, Hugo Albrecht, Robert W. Milne, Cobus Gerber, Mingfeng Yu & Shudong Wang. (2019) Discovery of N-Phenyl-4-(1H-pyrrol-3-yl)pyrimidin-2-amine Derivatives as Potent Mnk2 Inhibitors: Design, Synthesis, SAR Analysis, and Evaluation of in vitro Anti-leukaemic Activity. Medicinal Chemistry 15:6, pages 602-623.
Crossref
Joshua Casaos, Noah L. Gorelick, Sakibul Huq, John Choi, Yuanxuan Xia, Riccardo Serra, Raphael Felder, Tarik Lott, Richard E. Kast, Ian Suk, Henry Brem, Betty Tyler & Nicolas Skuli. (2019) The Use of Ribavirin as an Anticancer Therapeutic: Will It Go Viral?. Molecular Cancer Therapeutics 18:7, pages 1185-1194.
Crossref
Laurent Volpon, Michael J. Osborne & Katherine L.B. Borden. (2019) Biochemical and Structural Insights into the Eukaryotic Translation Initiation Factor eIF4E. Current Protein & Peptide Science 20:6, pages 525-535.
Crossref
Priyanka Shah O’Brien, Yue Xi, Justin R. Miller, Amy L. Brownell, Qinghua Zeng, George H. Yoo, Danielle M. Garshott, Matthew B. O’Brien, Anthony E. Galinato, Peter Cai, Neha Narula, Michael U. Callaghan, Randal J. Kaufman & Andrew M. Fribley. (2019) Disulfiram (Antabuse) Activates ROS-Dependent ER Stress and Apoptosis in Oral Cavity Squamous Cell Carcinoma. Journal of Clinical Medicine 8:5, pages 611.
Crossref
Karen A. Urtishak, Li-San Wang, Biljana Culjkovic-Kraljacic, James W. Davenport, Patrizia Porazzi, Tiffaney L. Vincent, David T. Teachey, Sarah K. Tasian, Jonni S. Moore, Alix E. Seif, Shenghao Jin, Jeffrey S. Barrett, Blaine W. Robinson, I-Ming L. Chen, Richard C. Harvey, Martin P. Carroll, Andrew J. Carroll, Nyla A. Heerema, Meenakshi Devidas, ZoAnn E. Dreyer, Joanne M. Hilden, Stephen P. Hunger, Cheryl L. Willman, Katherine L. B. Borden & Carolyn A. Felix. (2018) Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia. Oncogene 38:13, pages 2241-2262.
Crossref
Laura P.M.H. de RooijDerek C.H. ChanAva Keyvani ChahiKristin J. Hope. (2019) Post-transcriptional regulation in hematopoiesis: RNA binding proteins take control. Biochemistry and Cell Biology 97:1, pages 10-20.
Crossref
V. VENTURI, T. MASEK & M. POSPISEK. (2018) A Blood Pact: the Significance and Implications of eIF4E on Lymphocytic Leukemia. Physiological Research, pages 363-382.
Crossref
Haiyan Yang, Lohitha Rao Chennamaneni, Melvyn Wai Tuck Ho, Shi Hua Ang, Eldwin Sum Wai Tan, Duraiswamy Athisayamani Jeyaraj, Yoon Sheng Yeap, Boping Liu, Esther Hq Ong, Joma Kanikadu Joy, John Liang Kuan Wee, Perlyn Kwek, Priya Retna, Nurul Dinie, Thuy Thi Hanh Nguyen, Shi Jing Tai, Vithya Manoharan, Vishal Pendharkar, Choon Bing Low, Yun Shan Chew, Susmitha Vuddagiri, Kanda Sangthongpitag, Meng Ling Choong, May Ann Lee, Srinivasaraghavan Kannan, Chandra S. Verma, Anders Poulsen, Sharon Lim, Charles Chuah, Tiong Sin Ong, Jeffrey Hill, Alex Matter & Kassoum Nacro. (2018) Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia. Journal of Medicinal Chemistry 61:10, pages 4348-4369.
Crossref
Chuan Huang, Dongming Liang, Deirdre C. Tatomer & Jeremy E. Wilusz. (2018) A length-dependent evolutionarily conserved pathway controls nuclear export of circular RNAs. Genes & Development 32:9-10, pages 639-644.
Crossref
Amal M El-Naggar & Poul H Sorensen. (2018) Translational control of aberrant stress responses as a hallmark of cancer. The Journal of Pathology 244:5, pages 650-666.
Crossref
Jacob T. Jackson, Ashley P. Ng, Benjamin J. Shields, Sue Haupt, Ygal Haupt & Matthew P. McCormack. (2018) Hhex induces promyelocyte self-renewal and cooperates with growth factor independence to cause myeloid leukemia in mice. Blood Advances 2:4, pages 347-360.
Crossref
Padma-Sheela Jayaraman, Kerry S. Wadey, Sarah J. George & Kevin Gaston. 2018. Gene Expression and Regulation in Mammalian Cells - Transcription From General Aspects. Gene Expression and Regulation in Mammalian Cells - Transcription From General Aspects.
Arianna Piserà, Adele Campo & Salvatore Campo. (2018) Structure and functions of the translation initiation factor eIF4E and its role in cancer development and treatment. Journal of Genetics and Genomics 45:1, pages 13-24.
Crossref
Katherine Borden & Biljana Culkovic-Kraljacic. 2018. Nuclear-Cytoplasmic Transport. Nuclear-Cytoplasmic Transport 179 204 .
Androulla Elia, Ricky Henry-Grant, Charlotte Adiseshiah, Catherine Marboeuf, Rebecca J Buckley, Michael J Clemens, Satvinder Mudan & Stéphane Pyronnet. (2017) Implication of 4E-BP1 protein dephosphorylation and accumulation in pancreatic cancer cell death induced by combined gemcitabine and TRAIL. Cell Death & Disease 8:12.
Crossref
Hiba Ahmad Zahreddine, Biljana Culjkovic-Kraljacic, Audrey Emond, Filippa Pettersson, Ronald Midura, Mark Lauer, Sonia Del Rincon, Valbona Cali, Sarit Assouline, Wilson H Miller, Vincent Hascall & Katherine LB Borden. (2017) The eukaryotic translation initiation factor eIF4E harnesses hyaluronan production to drive its malignant activity. eLife 6.
Crossref
R M Kershaw, D Roberts, J Wragg, A M Shaaban, E Humphreys, J Halsall, L Price, R Bicknell, K Gaston & P-S Jayaraman. (2017) Proline-Rich Homeodomain protein (PRH/HHEX) is a suppressor of breast tumour growth. Oncogenesis 6:6, pages e346-e346.
Crossref
Laurent Volpon, Biljana Culjkovic-Kraljacic, Hye Seon Sohn, Alexis Blanchet-Cohen, Michael J. Osborne & Katherine L.B. Borden. (2017) A biochemical framework for eIF4E-dependent mRNA export and nuclear recycling of the export machinery. RNA 23:6, pages 927-937.
Crossref
Michael Niblock, Bradley N. Smith, Youn-Bok Lee, Valentina Sardone, Simon Topp, Claire Troakes, Safa Al-Sarraj, Claire S. Leblond, Patrick A. Dion, Guy A. Rouleau, Christopher E. Shaw & Jean-Marc Gallo. (2016) Retention of hexanucleotide repeat-containing intron in C9orf72 mRNA: implications for the pathogenesis of ALS/FTD. Acta Neuropathologica Communications 4:1.
Crossref
Kevin Gaston, Maria-Angela Tsitsilianos, Kerry Wadey & Padma-Sheela Jayaraman. (2016) Misregulation of the proline rich homeodomain (PRH/HHEX) protein in cancer cells and its consequences for tumour growth and invasion. Cell & Bioscience 6:1.
Crossref
Ernestina Saulle, Alessia Petronelli, Elvira Pelosi, Elena Coppotelli, Luca Pasquini, Ramona Ilari, Francesco Lo-Coco & Ugo Testa. (2016) PML-RAR alpha induces the downmodulation of HHEX: a key event responsible for the induction of an angiogenetic response. Journal of Hematology & Oncology 9:1.
Crossref
Peng Li, Sarah Diab, Mingfeng Yu, Julian Adams, Saiful Islam, Sunita K.C. Basnet, Hugo Albrecht, Robert Milne & Shudong Wang. (2016) Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells. Oncotarget 7:35, pages 56811-56825.
Crossref
Ewa M. Kosciuczuk, Diana Saleiro, Barbara Kroczynska, Elspeth M. Beauchamp, Frank Eckerdt, Gavin T. Blyth, Sameem M. Abedin, Francis J. Giles, Jessica K. Altman & Leonidas C. Platanias. (2016) Merestinib blocks Mnk kinase activity in acute myeloid leukemia progenitors and exhibits antileukemic effects in vitro and in vivo. Blood 128:3, pages 410-414.
Crossref
Arnaud Taminiau, Amandine Draime, Janne Tys, Barbara Lambert, Julie Vandeputte, Nathan Nguyen, Patricia Renard, Dirk Geerts & René Rezsöhazy. (2016) HOXA1 binds RBCK1/HOIL-1 and TRAF2 and modulates the TNF/NF-κB pathway in a transcription-independent manner. Nucleic Acids Research, pages gkw606.
Crossref
Laurent VolponBiljana Culjkovic-KraljacicMichael J. OsborneAnup RamtekeQingxiang Sun, Ashley Niesman, Yuh Min Chook & Katherine L. B. Borden. (2016) Importin 8 mediates m 7 G cap-sensitive nuclear import of the eukaryotic translation initiation factor eIF4E . Proceedings of the National Academy of Sciences 113:19, pages 5263-5268.
Crossref
Hong Zhou, Jiawei Zhang, Ying Gu, Xiaoxian Gan, Yichao Gan, Weiwei Zheng, Byung-Wook Kim, Xiaohua Xu, Xiaoya Lu, Qi Dong, Shu Zheng, Wendong Huang & Rongzhen Xu. (2015) Identification of a novel RNA giant nuclear body in cancer cells. Oncotarget 7:4, pages 4724-4734.
Crossref
Adam S. Arterbery & Clifford W. Bogue. (2016) Hhex Is Necessary for the Hepatic Differentiation of Mouse ES Cells and Acts via Vegf Signaling. PLOS ONE 11:1, pages e0146806.
Crossref
Ayuna Hattori, Kristina Buac & Takahiro Ito. 2016. RNA Processing. RNA Processing 153 188 .
Theodosia Teo, Frankie Lam, Mingfeng Yu, Yuchao Yang, Sunita K. C. Basnet, Hugo Albrecht, Matthew J. Sykes & Shudong Wang. (2015) Pharmacologic Inhibition of MNKs in Acute Myeloid Leukemia. Molecular Pharmacology 88:2, pages 380-389.
Crossref
Kanokporn Rithidech, Montree Tungjai, Witawat Jangiam, Louise Honikel, Chris Gordon, Xianyin Lai & Frank Witzmann. (2015) Proteomic Profiling of Hematopoietic Stem/Progenitor Cells after a Whole Body Exposure of CBA/CaJ Mice to Titanium (48Ti) Ions. Proteomes 3:3, pages 132-159.
Crossref
V Marfil, M Blazquez, F Serrano, J V Castell & R Bort. (2014) Growth-promoting and tumourigenic activity of c-Myc is suppressed by Hhex. Oncogene 34:23, pages 3011-3022.
Crossref
Mingfeng Yu, Peng Li, Sunita K.C. Basnet, Malika Kumarasiri, Sarah Diab, Theodosia Teo, Hugo Albrecht & Shudong Wang. (2015) Discovery of 4-(dihydropyridinon-3-yl)amino-5-methylthieno[2,3-d]pyrimidine derivatives as potent Mnk inhibitors: synthesis, structure–activity relationship analysis and biological evaluation. European Journal of Medicinal Chemistry 95, pages 116-126.
Crossref
Michael J. Clemens, Androulla Elia & Simon J. Morley. 2015. Systems Biology of Cancer. Systems Biology of Cancer 70 92 .
. 2015. Systems Biology of Cancer. Systems Biology of Cancer 35 92 .
Jacob T. Jackson, Chayanica Nasa, Wei ShiNicholas D. Huntington, Clifford W. Bogue, Warren S. Alexander & Matthew P. McCormack. (2015) A crucial role for the homeodomain transcription factor Hhex in lymphopoiesis. Blood 125:5, pages 803-814.
Crossref
Srinivasaraghavan Kannan, Anders Poulsen, Hai Yan Yang, Melvyn Ho, Shi Hua Ang, Tan Sum Wai Eldwin, Duraiswamy Athisayamani Jeyaraj, Lohitha Rao Chennamaneni, Boping Liu, Jeffrey Hill, Chandra S. Verma & Kassoum Nacro. (2014) Probing the Binding Mechanism of Mnk Inhibitors by Docking and Molecular Dynamics Simulations. Biochemistry 54:1, pages 32-46.
Crossref
Marwa H. SaiedJacek MarzecSabah KhalidPaul SmithGael MolloyBryan D. Young. (2015) Tritsomy 8 Acute Myeloid Leukemia Analysis Reveals New Insights of DNA Methylome with Identification of HHEX as Potential Diagnostic Marker . Biomarkers in Cancer 7, pages BIC.S19614.
Crossref
Fengfeng Wang, Lawrence W. C. Chan, Nancy B. Y. Tsui, S. C. Cesar Wong, Parco M. Siu, S. P. Yip & Benjamin Y. M. Yung. (2015) Coexpression Pattern Analysis of NPM1-Associated Genes in Chronic Myelogenous Leukemia. BioMed Research International 2015, pages 1-9.
Crossref
Michael J. Osborne & Katherine L. B. Borden. (2015) The eukaryotic translation initiation factor eIF4E in the nucleus: taking the road less traveled. Immunological Reviews 263:1, pages 210-223.
Crossref
Sara Karaki, Claudia Andrieu, Hajer Ziouziou & Palma Rocchi. 2015. 1 26 .
Martin Carroll. 2015. Targeted Therapy of Acute Myeloid Leukemia. Targeted Therapy of Acute Myeloid Leukemia 363 370 .
R M Kershaw, Y H Siddiqui, D Roberts, P-S Jayaraman & K Gaston. (2013) PRH/HHex inhibits the migration of breast and prostate epithelial cells through direct transcriptional regulation of Endoglin. Oncogene 33:49, pages 5592-5600.
Crossref
Cuiping Yu, Chaochao Luo, Bo Qu, Nagam Khudhair, Xinyu Gu, Yanli Zang, Chunmei Wang, Na Zhang, Qingzhang Li & Xuejun Gao. (2014) Molecular network including eIF1AX, RPS7, and 14-3-3γ regulates protein translation and cell proliferation in bovine mammary epithelial cells. Archives of Biochemistry and Biophysics 564, pages 142-155.
Crossref
Elianna M. Amin & Michael G. Kharas. 2014. Cancer Stem Cells. Cancer Stem Cells 417 434 .
James Uniacke, J. Kishan Perera, Gabriel Lachance, Camille B. Francisco & Stephen Lee. (2014) Cancer Cells Exploit eIF4E2-Directed Synthesis of Hypoxia Response Proteins to Drive Tumor Progression. Cancer Research 74:5, pages 1379-1389.
Crossref
Markus Reschke, Nina Seitzer, John G. Clohessy & Pier Paolo Pandolfi. 2014. Translation and Its Regulation in Cancer Biology and Medicine. Translation and Its Regulation in Cancer Biology and Medicine 467 486 .
J Carnevale, L Ross, A Puissant, V Banerji, R M Stone, D J DeAngelo, K N Ross & K Stegmaier. (2013) SYK regulates mTOR signaling in AML. Leukemia 27:11, pages 2118-2128.
Crossref
F Hariri, M Arguello, L Volpon, B Culjkovic-Kraljacic, T H Nielsen, J Hiscott, K K Mann & K L B Borden. (2013) The eukaryotic translation initiation factor eIF4E is a direct transcriptional target of NF-κB and is aberrantly regulated in acute myeloid leukemia. Leukemia 27:10, pages 2047-2055.
Crossref
Biljana Culjkovic-Kraljacic & Katherine L.B. Borden. (2013) Aiding and abetting cancer: mRNA export and the nuclear pore. Trends in Cell Biology 23:7, pages 328-335.
Crossref
Sharon LimTzuen Yih SawMin ZhangMatthew R. JanesKassoum NacroJeffrey HillAn Qi LimChia-Tien ChangDavid A. FrumanDavid A. RizzieriSoo Yong Tan, Hung FanCharles T. H. ChuahS. Tiong Ong. (2013) Targeting of the MNK–eIF4E axis in blast crisis chronic myeloid leukemia inhibits leukemia stem cell function. Proceedings of the National Academy of Sciences 110:25.
Crossref
Martin CarrollKatherine L.B. Borden. (2013) The Oncogene eIF4E: Using Biochemical Insights to Target Cancer. Journal of Interferon & Cytokine Research 33:5, pages 227-238.
Crossref
Michael J. Osborne, Laurent Volpon, Jack A. Kornblatt, Biljana Culjkovic-Kraljacic, Aurélie Baguet & Katherine L. B. Borden. (2013) eIF4E3 acts as a tumor suppressor by utilizing an atypical mode of methyl-7-guanosine cap recognition. Proceedings of the National Academy of Sciences 110:10, pages 3877-3882.
Crossref
Shirong Li, Jing Fu & Suzanne Lentzsch. 2013. Genetic and Molecular Epidemiology of Multiple Myeloma. Genetic and Molecular Epidemiology of Multiple Myeloma 43 57 .
Sarit Assouline, Eftihia Cocolakis & Katherine Borden. (2012) The Development of Novel Therapies for the Treatment of Acute Myeloid Leukemia (AML). Cancers 4:4, pages 1161-1179.
Crossref
Peter Noy, Anyaporn Sawasdichai, Padma-Sheela Jayaraman & Kevin Gaston. (2012) Protein kinase CK2 inactivates PRH/Hhex using multiple mechanisms to de-repress VEGF-signalling genes and promote cell survival. Nucleic Acids Research 40:18, pages 9008-9020.
Crossref
E. Kitroser, M. Pomeranz, G. Epstein Shochet, A. Fishman, L. Drucker, D. Sadeh-Mestechkin, M. Lishner & S. Tartakover-Matalon. (2012) The involvement of eukaryotic translation initiation factor 4E in extravillous trophoblast cell function. Placenta 33:9, pages 717-724.
Crossref
Yuqing Ge, Rubin Cheng, Yuhong Zhou, Jianping Shen, Laijun Peng, Xiaofeng Xu, Qun Dai, Pei Liu, Haibing Wang, Xiaoqiong Ma, Jia Jia & Zhe Chen. (2012) Cryptotanshinone induces cell cycle arrest and apoptosis of multidrug resistant human chronic myeloid leukemia cells by inhibiting the activity of eukaryotic initiation factor 4E. Molecular and Cellular Biochemistry 368:1-2, pages 17-25.
Crossref
Biljana Culjkovic-Kraljacic, Aurélie Baguet, Laurent Volpon, Abdellatif Amri & Katherine L.B. Borden. (2012) The Oncogene eIF4E Reprograms the Nuclear Pore Complex to Promote mRNA Export and Oncogenic Transformation. Cell Reports 2:2, pages 207-215.
Crossref
Bulent Ozpolat, Ugur Akar, Ibrahim Tekedereli, S. Neslihan Alpay, Magaly Barria, Baki Gezgen, Nianxiang Zhang, Kevin Coombes, Steve Kornblau & Gabriel Lopez-Berestein. (2012) PKC δ Regulates Translation Initiation through PKR and eIF2 α in Response to Retinoic Acid in Acute Myeloid Leukemia Cells . Leukemia Research and Treatment 2012, pages 1-17.
Crossref
Bin Zhang, Gayatri Arun, Yuntao S. Mao, Zsolt Lazar, Gene Hung, Gourab Bhattacharjee, Xiaokun Xiao, Carmen J. Booth, Jie Wu, Chaolin Zhang & David L. Spector. (2012) The lncRNA Malat1 Is Dispensable for Mouse Development but Its Transcription Plays a cis-Regulatory Role in the Adult. Cell Reports 2:1, pages 111-123.
Crossref
Xiaoqi Chen, David J. Kopecky, Jeff Mihalic, Shawn Jeffries, Xiaoshan Min, Julie Heath, Jeff Deignan, SuJen Lai, Zice Fu, Cristiano Guimaraes, Shanling Shen, Shyun Li, Sheree Johnstone, Stephen Thibault, Haoda Xu, Mario Cardozo, Wang Shen, Nigel Walker, Frank Kayser & Zhulun Wang. (2012) Structure-Guided Design, Synthesis, and Evaluation of Guanine-Derived Inhibitors of the eIF4E mRNA–Cap Interaction. Journal of Medicinal Chemistry 55:8, pages 3837-3851.
Crossref
Anshuman Shukla, Nicholas M. Burton, Padma-Sheela Jayaraman & Kevin Gaston. (2012) The Proline Rich Homeodomain Protein PRH/Hhex Forms Stable Oligomers That Are Highly Resistant to Denaturation. PLoS ONE 7:4, pages e35984.
Crossref
Nadeem Siddiqui & Katherine L. B. Borden. (2012) mRNA export and cancer. Wiley Interdisciplinary Reviews: RNA 3:1, pages 13-25.
Crossref
B C Kraljacic, M Arguello, A Amri, G Cormack & K Borden. (2011) Inhibition of eIF4E with ribavirin cooperates with common chemotherapies in primary acute myeloid leukemia specimens. Leukemia 25:7, pages 1197-1200.
Crossref
Mahadeo A. SukhaiPaul A. SpagnuoloScott WeirJames Kasper, Lavonne Patton & Aaron D. Schimmer. (2011) New sources of drugs for hematologic malignancies. Blood 117:25, pages 6747-6755.
Crossref
Di Wu, Kazuyuki Matsushita, Hisahiro Matsubara, Fumio Nomura & Takeshi Tomonaga. (2010) An alternative splicing isoform of eukaryotic initiation factor 4H promotes tumorigenesis in vivo and is a potential therapeutic target for human cancer . International Journal of Cancer 128:5, pages 1018-1030.
Crossref
Edwin Chen, Xiaoyong Huang, Yanzhen Zheng, You-Jun Li, Alden Chesney, Yaacov Ben-David, Eric Yang & Margaret R Hough. (2010) Phosphorylation of HOX11/TLX1 on Threonine-247 during mitosis modulates expression of cyclin B1. Molecular Cancer 9:1.
Crossref
A. Soufi, A. Sawasdichai, A. Shukla, P. Noy, T. Dafforn, C. Smith, P.-S. Jayaraman & K. Gaston. (2010) DNA compaction by the higher-order assembly of PRH/Hex homeodomain protein oligomers. Nucleic Acids Research 38:21, pages 7513-7525.
Crossref
Jessica K. Altman, Heather Glaser, Antonella Sassano, Sonali Joshi, Takeshi Ueda, Rie Watanabe-Fukunaga, Rikiro Fukunaga, Martin S. Tallman & Leonidas C. Platanias. (2010) Negative Regulatory Effects of Mnk Kinases in the Generation of Chemotherapy-Induced Antileukemic Responses. Molecular Pharmacology 78:4, pages 778-784.
Crossref
Laurent Volpon, Michael J. Osborne, Althea A. Capul, Juan C. de la Torre & Katherine L. B. Borden. (2010) Structural characterization of the Z RING-eIF4E complex reveals a distinct mode of control for eIF4E. Proceedings of the National Academy of Sciences 107:12, pages 5441-5446.
Crossref
Patrick R. HagnerAbraham Schneider & Ronald B. Gartenhaus. (2010) Targeting the translational machinery as a novel treatment strategy for hematologic malignancies. Blood 115:11, pages 2127-2135.
Crossref
Ryan J.O. Dowling, Ivan Topisirovic, Bruno D. Fonseca & Nahum Sonenberg. (2010) Dissecting the role of mTOR: Lessons from mTOR inhibitors. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 1804:3, pages 433-439.
Crossref
Vanessa Marfil, Marta Moya, Christophe E. Pierreux, Jose V. Castell, Frédéric P. Lemaigre, Francisco X. Real & Roque Bort. (2010) Interaction between Hhex and SOX13 Modulates Wnt/TCF Activity. Journal of Biological Chemistry 285:8, pages 5726-5737.
Crossref
K. V. Bogdanov. (2010) Significance of mitotic spindle checkpoint genes in leukemia. Cell and Tissue Biology 3:6, pages 503-510.
Crossref
Jonathan E. Ploski, Ivan Topisirovic, Kevin W. Park, Katherine L. B. Borden & Aurelian Radu. (2009) A mechanism of nucleocytoplasmic trafficking for the homeodomain protein PRH. Molecular and Cellular Biochemistry 332:1-2, pages 173-181.
Crossref
Martin Carroll. (2009) Taking aim at protein translation in AML. Blood 114:8, pages 1458-1459.
Crossref
Sarit AssoulineBiljana CuljkovicEftihia CocolakisCaroline RousseauNathalie BesluAbdellatif AmriStephen CaplanBrian Leber, Denis-Claude Roy, Wilson H. MillerJrJrKatherine L. B. Borden. (2009) Molecular targeting of the oncogene eIF4E in acute myeloid leukemia (AML): a proof-of-principle clinical trial with ribavirin. Blood 114:2, pages 257-260.
Crossref
Abdenour Soufi, Peter Noy, Malcolm Buckle, Anyaporn Sawasdichai, Kevin Gaston & Padma-Sheela Jayaraman. (2009) CK2 phosphorylation of the PRH/Hex homeodomain functions as a reversible switch for DNA binding. Nucleic Acids Research 37:10, pages 3288-3300.
Crossref
Ivan Topisirovic, Nadeem Siddiqui, Vincent Leroux Lapointe, Matthias Trost, Pierre Thibault, Catherine Bangeranye, Serafin Piñol-Roma & Katherine L B Borden. (2009) Molecular dissection of the eukaryotic initiation factor 4E (eIF4E) export-competent RNP. The EMBO Journal 28:8, pages 1087-1098.
Crossref
Thaer Khoury, Sadir Alrawi, Nithva Ramnath, Qiang Li, Melissa Grimm, Jennifer Black & Dongfeng Tan. (2009) Eukaryotic Initiation Factor-4E and Cyclin D1 Expression Associated with Patient Survival in Lung Cancer. Clinical Lung Cancer 10:1, pages 58-66.
Crossref
Biljana Culjkovic & Katherine L. Borden. (2009) Understanding and Targeting the Eukaryotic Translation Initiation Factor eIF4E in Head and Neck Cancer. Journal of Oncology 2009, pages 1-12.
Crossref
Cecile DesjobertPeter NoyTracey SwinglerHannah  WilliamsKevin GastonPadma-Sheela Jayaraman. (2008) The PRH/Hex repressor protein causes nuclear retention of Groucho/TLE co-repressors. Biochemical Journal 417:1, pages 121-132.
Crossref
Godfrey GrechMontserrat Blázquez-DomingoAndrea Kolbus, Walbert J. BakkerErnst W. Müllner, Hartmut Beug & Marieke von Lindern. (2008) Igbp1 is part of a positive feedback loop in stem cell factor–dependent, selective mRNA translation initiation inhibiting erythroid differentiation. Blood 112:7, pages 2750-2760.
Crossref
Keith Tan, Biljana Culjkovic, Abdellatif Amri & Katherine L.B. Borden. (2008) Ribavirin targets eIF4E dependent Akt survival signaling. Biochemical and Biophysical Research Communications 375:3, pages 341-345.
Crossref
Bulent Ozpolat, Ugur Akar, Isabel Zorrilla-Calancha, Pablo Vivas-Mejia, Marian Acevedo-Alvarez & Gabriel Lopez-Berestein. (2008) Death-associated protein 5 (DAP5/p97/NAT1) contributes to retinoic acid-induced granulocytic differentiation and arsenic trioxide-induced apoptosis in acute promyelocytic leukemia. Apoptosis 13:7, pages 915-928.
Crossref
Duane C. Hassane, Monica L. Guzman, Cheryl Corbett, Xiaojie Li, Ramzi Abboud, Fay Young, Jane L. Liesveld, Martin Carroll & Craig T. Jordan. (2008) Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data. Blood 111:12, pages 5654-5662.
Crossref
Abdenour SoufiPadma-Sheela Jayaraman. (2008) PRH/Hex: an oligomeric transcription factor and multifunctional regulator of cell fate. Biochemical Journal 412:3, pages 399-413.
Crossref
Biljana Culjkovic, Keith Tan, Slobodanka Orolicki, Abdellatif Amri, Sylvain Meloche & Katherine L.B. Borden. (2008) The eIF4E RNA regulon promotes the Akt signaling pathway. The Journal of Cell Biology 181:1, pages 51-63.
Crossref
A Phillips & J P Blaydes. (2007) MNK1 and EIF4E are downstream effectors of MEKs in the regulation of the nuclear export of HDM2 mRNA. Oncogene 27:11, pages 1645-1649.
Crossref
A Elia, C Constantinou & M J Clemens. (2007) Effects of protein phosphorylation on ubiquitination and stability of the translational inhibitor protein 4E-BP1. Oncogene 27:6, pages 811-822.
Crossref
Ian G. Goodfellow & Lisa O. Roberts. (2008) Eukaryotic initiation factor 4E. The International Journal of Biochemistry & Cell Biology 40:12, pages 2675-2680.
Crossref
Monica L. GuzmanRandall M. RossiSundar NeelakantanXiaojie LiCheryl A. CorbettDuane C. HassaneMichael W. BeckerJohn M. BennettEdmund SullivanJoshua L. LachowiczAndrew VaughanChristopher J. SweeneyWilliam Matthews, Martin Carroll, Jane L. LiesveldPeter A. CrooksCraig T. Jordan. (2007) An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells. Blood 110:13, pages 4427-4435.
Crossref
Michael J. Clemens. 2005. The Cancer Handbook. The Cancer Handbook.
Biljana Culjkovic, Ivan Topisirovic, Lucy Skrabanek, Melisa Ruiz-Gutierrez & Katherine L.B. Borden. (2006) eIF4E is a central node of an RNA regulon that governs cellular proliferation. Journal of Cell Biology 175:3, pages 415-426.
Crossref
Laurent Volpon, Michael J Osborne, Ivan Topisirovic, Nadeem Siddiqui & Katherine LB Borden. (2006) Cap-free structure of eIF4E suggests a basis for conformational regulation by its ligands. The EMBO Journal 25:21, pages 5138-5149.
Crossref
Ola Larsson, David M. Perlman, Danhua Fan, Cavan S. Reilly, Mark Peterson, Cecilia Dahlgren, Zicai Liang, Shunan Li, Vitaly A. Polunovsky, Claes Wahlestedt & Peter B. Bitterman. (2006) Apoptosis resistance downstream of eIF4E: posttranscriptional activation of an anti-apoptotic transcript carrying a consensus hairpin structure. Nucleic Acids Research 34:16, pages 4375-4386.
Crossref
Abdenour Soufi, Kevin Gaston & Padma-Sheela Jayaraman. (2006) Purification and characterisation of the PRH homeodomain: Removal of the N-terminal domain of PRH increases the PRH homeodomain–DNA interaction. International Journal of Biological Macromolecules 39:1-3, pages 45-50.
Crossref
Piotr Smolewski. (2006) Recent developments in targeting the mammalian target of rapamycin (mTOR) kinase pathway. Anti-Cancer Drugs 17:5, pages 487-494.
Crossref
Abdenour Soufi, Corinne Smith, Anthony R. Clarke, Kevin Gaston & Padma-Sheela Jayaraman. (2006) Oligomerisation of the Developmental Regulator Proline Rich Homeodomain (PRH/Hex) is Mediated by a Novel Proline-rich Dimerisation Domain. Journal of Molecular Biology 358:4, pages 943-962.
Crossref
Jean L. Nakamura & Daphne A. Haas-Kogan. 2006. Handbook of Brain Tumor Chemotherapy. Handbook of Brain Tumor Chemotherapy 185 192 .
Ningxi Zhu, Lubing Gu, Harry W. Findley & Muxiang Zhou. (2005) Transcriptional repression of the eukaryotic initiation factor 4E gene by wild type p53. Biochemical and Biophysical Research Communications 335:4, pages 1272-1279.
Crossref
S J Morley, M J Coldwell & M J Clemens. (2005) Initiation factor modifications in the preapoptotic phase. Cell Death & Differentiation 12:6, pages 571-584.
Crossref
Biljana Culjkovic, Ivan Topisirovic, Lucy Skrabanek, Melisa Ruiz-Gutierrez & Katherine L.B. Borden. (2005) eIF4E promotes nuclear export of cyclin D1 mRNAs via an element in the 3′UTR. Journal of Cell Biology 169:2, pages 245-256.
Crossref
Mahmoud Djavani, Ivan Topisirovic, Juan Carlos Zapata, Mariola Sadowska, Yida Yang, Juan Rodas, Igor S. Lukashevich, Clifford W. Bogue, C. David Pauza, Katherine L. B. Borden & Maria S. Salvato. (2005) The Proline-Rich Homeodomain (PRH/HEX) Protein Is Down-Regulated in Liver during Infection with Lymphocytic Choriomeningitis Virus. Journal of Virology 79:4, pages 2461-2473.
Crossref
Yang Guo, Jyoti Harwalkar, Dennis W Stacey & Masahiro Hitomi. (2004) Destabilization of cyclin D1 message plays a critical role in cell cycle exit upon mitogen withdrawal. Oncogene 24:6, pages 1032-1042.
Crossref
Alex Kentsis, Ivan Topisirovic, Biljana Culjkovic, Ling Shao & Katherine L. B. Borden. (2004) Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap. Proceedings of the National Academy of Sciences 101:52, pages 18105-18110.
Crossref
Jennifer Worch, Lara Tickenbrock, Joachim Schwäble, Björn Steffen, Thomas Cauvet, Barbara Mlody, Horst Buerger, H Phillip Koeffler, Wolfgang E Berdel, Hubert Serve & Carsten Müller-Tidow. (2004) The serine-threonine kinase MNK1 is post-translationally stabilized by PML-RARα and regulates differentiation of hematopoietic cells. Oncogene 23:57, pages 9162-9172.
Crossref
Ivan Topisirovic, Melisa Ruiz-Gutierrez & Katherine L. B. Borden. (2004) Phosphorylation of the Eukaryotic Translation Initiation Factor eIF4E Contributes to Its Transformation and mRNA Transport Activities. Cancer Research 64:23, pages 8639-8642.
Crossref
Tracey E. Swingler, Kirstin L. Bess, Jing Yao, Stefano Stifani & Padma-Sheela Jayaraman. (2004) The Proline-rich Homeodomain Protein Recruits Members of the Groucho/Transducin-like Enhancer of Split Protein Family to Co-repress Transcription in Hematopoietic Cells. Journal of Biological Chemistry 279:33, pages 34938-34947.
Crossref
Yaël Mamane, Emmanuel Petroulakis, Liwei Rong, Kaori Yoshida, Lian Wee Ler & Nahum Sonenberg. (2004) eIF4E – from translation to transformation. Oncogene 23:18, pages 3172-3179.
Crossref
Frank McCormick. (2004) Survival pathways meet their end. Nature 428:6980, pages 267-269.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.